Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Heart Failure
Description
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. MeSH
Hierarchy View
Subtype Terms (5)
Cardio-Renal Syndrome
21 drugs (18 approved, 3 experimental)
Dyspnea, Paroxysmal
2 approved drugs
Edema, Cardiac
1 approved drug
Heart Failure, Diastolic
118 drugs (68 approved, 50 experimental)
Heart Failure, Systolic
76 drugs (49 approved, 27 experimental)
Approved Indicated Drugs (69)
Phase 3 Indicated Drugs (63)
Phase 2 Indicated Drugs (126)
albumin iodinated i-131 serum (Megatope)
allogeneic hematopoietic stem cells (Hemacord)
autologous mesenchymal stem cells
Other Experimental Indicated Drugs (48)
Organization Involved with Phase 4 Indications (263)
American College of Clinical Pharmacy
Associazione Nazionale Medici Cardiologi Ospedalieri
Autonomous University of Madrid
Badalona Hospital Germans Trias i Pujol
Casa Sollievo della Sofferenza IRCCS
Case Western Reserve University
Catholic University of Sacred Heart, Rome
China International Medical Foundation
China Resources Zizhu Pharmaceutical Co., Ltd.
Chinese Academy of Medical Sciences
Clinica Universidad de Navarra
Danish Council for Independent Research
European Foundation for the Study of Diabetes
Fundacion Favaloro Para La Docencia e Investigacion Medica
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Heart and Stroke Foundation of Canada
HEART FAILURE CENTER INSTITUTO NACIONAL DE CARDIOLOGIA
Heart Failure Study Group, Spanish Society of Internal Medicine
Hospital General Universitario Gregorio Marañon
Icahn School of Medicine at Mount Sinai
Institute of Cardiology, Warsaw, Poland
Institut Hospital del Mar d'Investigacions Mèdiques
Institut National de la Santé Et de la Recherche Médicale, France
Katholieke Universiteit Leuven
Kyoto Prefectural University of Medicine
La Fundacion Favaloro para la Investigacion y la Docencia Medica
Nanyang Technological University
National Center for Research Resources (NCRR)
National Cheng Kung University
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of General Medical Sciences (NIGMS)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Aging (NIA)
National Institutes of Health (NIH)
National University of Ireland
National University of Singapore
Newark Beth Israel Medical Center
People's Liberation Army of China
Russian Academy of Medical Sciences
Second Military Medical University
Shields, Shields and Associates
Silesian University of Medicine
Society of Specialists in Heart Failure
Southlake Regional Health Centre
Spanish Society of Internal Medicine
State University of New York, Syracuse
St. Luke's-Roosevelt Hospital Center
Taipei Veteran General hospital
Texas Cardiac Arrhythmia Institute
The Aase og Ejnar Danielsen Foundation
The Danish Regions: Foundation for Medical Research
The University of Texas, Dallas
Universidad Autonoma de Barcelona
Universidad Autonoma de Madrid
Universidad Complutense de Madrid
University of California, Los Angeles
University of Campania Luigi Vanvitelli
University of Illinois at Chicago
University of Las Palmas de Gran Canaria
University of Medicine and Dentistry of New Jersey
University of North Carolina at Chapel Hill
University of Roma La Sapienza
University of Southern California
University of Texas at Houston
University of Texas, Galveston
University of Texas, San Antonio
Virginia Commonwealth University
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 3 Indications (161)
Andalusian Initiative for Advanced Therapies
Andalusian Initiative in Advanced Therapies
Aristotle University of Thessaloniki
Aspirus Heart and Vascular Institute-Research and Education
Blekinge County Council Hospital
Cardiovascular Clinical Science Foundation
Cardiovascular Clinical Studies, Inc.
Caritas Teaching Hospital, Bucharest
Carol Davila University of Medicine and Pharmacy
China Three Gorges University, Yichang, China
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Department of Health and Human Services
Federal University of Rio Grande do Sul
Fundación Cardiovascular de Colombia
Hospital dos Servidores do Estado - Rio de Janeiro
Hospital Regional Universitario Carlos Haya
Hospital Universitario Puerta del Mar
Institut de Recerca Biomèdica de Lleida
Mashhad University of Medical Sciences
Medical University of South Carolina
National Center for Complementary and Integrative Health (NCCIH)
National Heart Foundation, Australia
National Institute of Mental Health (NIMH)
New England Research Institutes
Shandong Province Qianfoshan Hospital
Shanghai Putuo District Central Hospital
United Arab Emirates University
University of California, San Francisco
University of Modena and Reggio Emilia
University of Naples Frederico II
University Teaching Hospital Hall in Tirol
Univerzitetska Decja Klinika Belgrade
Vita-Salute University of Milano. Italy
VZW Cardiovascular Research Center Aalst
Organization Involved with Phase 2 Indications (164)
Accel Research Sites - DeLand Clinical Research Unit
American Academy of Sleep Medicine
Bambino Gesù Hospital and Research Institute
CC Iliescu Heart Disease Institute, Bucharest
China Academy of Chinese Medical Sciences
City of Hope National Medical Center
Emergency Hospital Loreasca, Bucharest
Escuela de Medicina y Ciencias de la Salud. Tecnológico de Monterrey. Monterrey. México
Fundação de Amparo à Pesquisa do Estado de São Paulo
Fundacion Investigacion y Desarrollo
Hamilton Health Sciences Corporation
Henan University of Traditional Chinese Medicine
Hospital Universitario Ramon y Cajal
Inner Mongolia International Mongolian Hospital
Insitutul de Boli Cardiovasculare C.C. Iliescu Bucuresti, Bucharest - ROMANIA
International Heart Institute of Montana
Medical City Children's Hospital, Dallas
National Cancer Institute (NCI)
National Institute for Health Research, United Kingdom
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Netherlands Foundation for Cardiovascular Excellence
Oregon Health and Science University
Postgraduate Institute of Medical Education and Research
SCIRENT Clinical Research and Science d.o.o.
Sclnow Biotechnology Co., Ltd.
Shanghai University of Traditional Chinese Medicine
Organization Involved with Phase 1 Indications (40)
Organization Involved with Other Experimental Indications (60)
Instituto Nacional de Enfermedades Respiratorias
Instituto Nacional De Enfermedades Respiratorias Ismael Cosio Villegas
National Institute of Nursing Research (NINR)
Rajaie Cardiovascular Medical and Research Center
Scottsdale Cardiovascular Research Institute
Sint Antonius Hospital, Nieuwegein
St. Antonius Hospital, Nieuwegein
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
